Obesity drug Follow-Up: no new doses, just safety watch
NCT ID NCT07153172
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 30 times
Summary
This study follows up with people who previously received the experimental obesity drug INV-347 in an earlier study. Participants will not receive any new treatment. The goal is to track any side effects and measure how long the drug stays in the body. About 91 adults aged 18 and older will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Syneos Health Clinique
RECRUITINGQuébec, G1P 0A2, Canada
Conditions
Explore the condition pages connected to this study.